• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ILDgenDB:间质性肺疾病(ILDs)综合遗传知识库。

ILDgenDB: integrated genetic knowledge resource for interstitial lung diseases (ILDs).

机构信息

Department of Biotechnology and Bioinformatics, Jaypee University of Information Technology, Waknaghat, Solan, Himachal Pradesh 173234, India.

Department of Pulmonary Medicine, Indira Gandhi Medical College, Shimla, Himachal Pradesh 171001, India.

出版信息

Database (Oxford). 2018 Jan 1;2018. doi: 10.1093/database/bay053.

DOI:10.1093/database/bay053
PMID:29897484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6007225/
Abstract

Interstitial lung diseases (ILDs) are a diverse group of ∼200 acute and chronic pulmonary disorders that are characterized by variable amounts of inflammation, fibrosis and architectural distortion with substantial morbidity and mortality. Inaccurate and delayed diagnoses increase the risk, especially in developing countries. Studies have indicated the significant roles of genetic elements in ILDs pathogenesis. Therefore, the first genetic knowledge resource, ILDgenDB, has been developed with an objective to provide ILDs genetic data and their integrated analyses for the better understanding of disease pathogenesis and identification of diagnostics-based biomarkers. This resource contains literature-curated disease candidate genes (DCGs) enriched with various regulatory elements that have been generated using an integrated bioinformatics workflow of databases searches, literature-mining and DCGs-microRNA (miRNAs)-single nucleotide polymorphisms (SNPs) association analyses. To provide statistical significance to disease-gene association, ILD-specificity index and hypergeomatric test scores were also incorporated. Association analyses of miRNAs, SNPs and pathways responsible for the pathogenesis of different sub-classes of ILDs were also incorporated. Manually verified 299 DCGs and their significant associations with 1932 SNPs, 2966 miRNAs and 9170 miR-polymorphisms were also provided. Furthermore, 216 literature-mined and proposed biomarkers were identified. The ILDgenDB resource provides user-friendly browsing and extensive query-based information retrieval systems. Additionally, this resource also facilitates graphical view of predicted DCGs-SNPs/miRNAs and literature associated DCGs-ILDs interactions for each ILD to facilitate efficient data interpretation. Outcomes of analyses suggested the significant involvement of immune system and defense mechanisms in ILDs pathogenesis. This resource may potentially facilitate genetic-based disease monitoring and diagnosis.Database URL: http://14.139.240.55/ildgendb/index.php.

摘要

间质性肺疾病(ILDs)是一组约 200 种急性和慢性肺部疾病,其特征是炎症、纤维化和结构扭曲程度不同,发病率和死亡率很高。不准确和延迟的诊断会增加风险,尤其是在发展中国家。研究表明,遗传因素在ILDs 的发病机制中起着重要作用。因此,第一个遗传知识库——ILDgenDB 已经开发出来,旨在为更好地了解疾病发病机制和识别基于诊断的生物标志物提供 ILD 遗传数据及其综合分析。该资源包含文献整理的疾病候选基因(DCGs),这些基因富含各种调控元件,这些元件是通过数据库搜索、文献挖掘和 DCGs- microRNA (miRNAs)-单核苷酸多态性 (SNP) 关联分析的综合生物信息学工作流程生成的。为了提供疾病基因关联的统计学意义,ILD 特异性指数和超几何测试分数也被纳入其中。还对不同亚类 ILD 发病机制的 miRNA、SNP 和途径的关联分析进行了分析。还提供了手动验证的 299 个 DCGs 及其与 1932 个 SNPs、2966 个 miRNAs 和 9170 个 miR-多态性的显著关联。此外,还确定了 216 个文献挖掘和提出的生物标志物。ILDgenDB 资源提供了用户友好的浏览和广泛的基于查询的信息检索系统。此外,该资源还为每个 ILD 提供了预测的 DCGs-SNPs/miRNAs 和与文献相关的 DCGs-ILDs 相互作用的图形视图,以方便有效地解释数据。分析结果表明,免疫系统和防御机制在 ILDs 的发病机制中起着重要作用。该资源可能有助于基于遗传的疾病监测和诊断。数据库网址:http://14.139.240.55/ildgendb/index.php。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992f/6007225/eb4e5b004be0/bay053f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992f/6007225/ddc762b1d6f5/bay053f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992f/6007225/7ec96661d034/bay053f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992f/6007225/36b1a5c61c9a/bay053f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992f/6007225/c09dd808b806/bay053f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992f/6007225/eb4e5b004be0/bay053f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992f/6007225/ddc762b1d6f5/bay053f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992f/6007225/7ec96661d034/bay053f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992f/6007225/36b1a5c61c9a/bay053f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992f/6007225/c09dd808b806/bay053f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992f/6007225/eb4e5b004be0/bay053f5.jpg

相似文献

1
ILDgenDB: integrated genetic knowledge resource for interstitial lung diseases (ILDs).ILDgenDB:间质性肺疾病(ILDs)综合遗传知识库。
Database (Oxford). 2018 Jan 1;2018. doi: 10.1093/database/bay053.
2
MSDD: a manually curated database of experimentally supported associations among miRNAs, SNPs and human diseases.MSDD:一个手动整理的数据库,其中包含实验支持的 miRNA、SNP 和人类疾病之间的关联。
Nucleic Acids Res. 2018 Jan 4;46(D1):D181-D185. doi: 10.1093/nar/gkx1035.
3
Systems biology of interstitial lung diseases: integration of mRNA and microRNA expression changes.间质性肺疾病的系统生物学:mRNA 和 microRNA 表达变化的整合。
BMC Med Genomics. 2011 Jan 17;4:8. doi: 10.1186/1755-8794-4-8.
4
ILDGDB: a manually curated database of genomics, transcriptomics, proteomics and drug information for interstitial lung diseases.ILDGDB:一个经过人工整理的基因组学、转录组学、蛋白质组学和药物信息数据库,用于间质性肺疾病。
BMC Pulm Med. 2020 Dec 11;20(1):323. doi: 10.1186/s12890-020-01350-0.
5
miRiaD: A Text Mining Tool for Detecting Associations of microRNAs with Diseases.miRiaD:一种用于检测微小RNA与疾病关联的文本挖掘工具。
J Biomed Semantics. 2016 Apr 29;7(1):9. doi: 10.1186/s13326-015-0044-y.
6
miRSponge: a manually curated database for experimentally supported miRNA sponges and ceRNAs.miRSponge:一个经人工整理的数据库,用于收录实验支持的miRNA海绵和竞争性内源RNA。
Database (Oxford). 2015 Sep 30;2015. doi: 10.1093/database/bav098. Print 2015.
7
Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin.不明原因间质性肺疾病的遗传易感性及发病机制
Eur Respir J Suppl. 2001 Sep;32:17s-29s.
8
A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.一项针对丹麦间质性肺疾病患者的队列研究:负担、严重程度、治疗与生存情况。
Dan Med J. 2015 Apr;62(4):B5069.
9
OncomiRDB: a database for the experimentally verified oncogenic and tumor-suppressive microRNAs.OncomiRDB:一个经实验验证的致癌和肿瘤抑制 microRNA 的数据库。
Bioinformatics. 2014 Aug 1;30(15):2237-8. doi: 10.1093/bioinformatics/btu155. Epub 2014 Mar 20.
10
miR2Diabetes: A Literature-Curated Database of microRNA Expression Patterns, in Diabetic Microvascular Complications.miR2Diabetes:一个经文献编纂的数据库,包含糖尿病微血管并发症中 microRNA 表达模式。
Genes (Basel). 2019 Oct 9;10(10):784. doi: 10.3390/genes10100784.

引用本文的文献

1
Recent Advances of Artificial Intelligence Applications in Interstitial Lung Diseases.人工智能在间质性肺疾病中的应用新进展
Diagnostics (Basel). 2023 Jul 6;13(13):2303. doi: 10.3390/diagnostics13132303.

本文引用的文献

1
Interstitial Lung Disease in India. Results of a Prospective Registry.印度间质性肺病。一项前瞻性登记研究结果。
Am J Respir Crit Care Med. 2017 Mar 15;195(6):801-813. doi: 10.1164/rccm.201607-1484OC.
2
Therapeutic targets in fibrotic pathways.纤维化途径中的治疗靶点。
Cytokine. 2016 Dec;88:193-195. doi: 10.1016/j.cyto.2016.09.008. Epub 2016 Sep 19.
3
miR-155 in the progression of lung fibrosis in systemic sclerosis.微小RNA-155在系统性硬化症肺纤维化进展中的作用
Arthritis Res Ther. 2016 Jul 5;18(1):155. doi: 10.1186/s13075-016-1054-6.
4
Circulating let-7 levels in plasma and extracellular vesicles correlate with hepatic fibrosis progression in chronic hepatitis C.血浆和细胞外囊泡中循环的let-7水平与慢性丙型肝炎肝纤维化进展相关。
Hepatology. 2016 Sep;64(3):732-45. doi: 10.1002/hep.28660. Epub 2016 Jul 7.
5
Genetic Susceptibility to Interstitial Lung Disease Associated with Systemic Sclerosis.系统性硬化症相关间质性肺疾病的遗传易感性
Clin Med Insights Circ Respir Pulm Med. 2016 Mar 13;9(Suppl 1):135-40. doi: 10.4137/CCRPM.S23312. eCollection 2015.
6
Interstitial lung diseases in the hospitalized patient.住院患者的间质性肺疾病
BMC Med. 2015 Sep 25;13:245. doi: 10.1186/s12916-015-0487-0.
7
Idiopathic pulmonary fibrosis in BRIC countries: the cases of Brazil, Russia, India, and China.金砖国家的特发性肺纤维化:巴西、俄罗斯、印度和中国的病例
BMC Med. 2015 Sep 24;13:237. doi: 10.1186/s12916-015-0495-0.
8
Cancer biomarker discovery and validation.癌症生物标志物的发现与验证。
Transl Cancer Res. 2015 Jun;4(3):256-269. doi: 10.3978/j.issn.2218-676X.2015.06.04.
9
Facts and promises on lung biomarkers in interstitial lung diseases.间质性肺疾病中肺部生物标志物的事实与前景
Expert Rev Respir Med. 2015 Aug;9(4):437-57. doi: 10.1586/17476348.2015.1062367. Epub 2015 Jul 4.
10
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.1990年至2013年188个国家301种急慢性疾病和损伤的全球、区域及国家发病率、患病率和伤残调整生命年:全球疾病负担研究2013的系统分析
Lancet. 2015 Aug 22;386(9995):743-800. doi: 10.1016/S0140-6736(15)60692-4. Epub 2015 Jun 7.